Clinical Trial Update: An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the efficacy and safety of Licroca Depot, a controlled-release product injected into the prostate, was completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Licroca Depot

Snippet

Sponsor: Lidds AB | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-01-19